RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Looking at the latest update for the CX-1739 RD trial on Clinicaltrials.gov (link below), it was updated July 27 and says -


https://clinicaltrials.gov/ct2/show/NCT02735629?term=cx1739&rank=1



"Enrollment: 18
Study Start Date: March 2016
Estimated Study Completion Date: September 2016
Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure"



So looks like this has slipped from the previous info we had from an earlier press release which said -


"The Company expects to complete the final data collection with respect to the clinical trial by the end of May 2016, and to issue a report on the results of the clinical trial during the third quarter of 2016."


So the 3rd quarter of 2016 is still valid, but the final data collection must have slipped from end of May to August.

I thought the May date seemed quick, based on how long the previous CX-717 RD trial had taken. But in any event, the data should hopefully be released by the end of September at the latest, barring any additional delays. One thing you learn in biotech is how to wait, lol..